[EpochTimesJuly292021](Epoch Times reporter Tian Rui, Sydney, Australia) The Australian Medical Supplies Administration (TGA) disclosed in its updated weekly report on July 29 that another 6 people across Australia were vaccinated against AZ (AstraZeneca, AstraZeneca) After experiencing thrombotic symptoms.
The 6 people are two 61-year-old NSW women, a 71-year-old NSW man, a 72-year-old Queensland man, a 77-year-old Victorian man and a 74-year-old Victorian man.
Among them, a 74-year-old Victorian man is a confirmed case of thrombotic thrombocytopenia syndrome (TTS), and the other 5 cases are classified as probable cases.
The Independent Vaccine Safety Investigation Group (VSIG) believes that the previous three possible cases of thrombotic thrombocytopenia syndrome after the second shot of AZ vaccine are unlikely to be related to the AZ vaccine.
As of July 25, Australians had received approximately 6.3 million doses of the AZ vaccine, and a total of 90 cases of thrombosis had occurred.
The Medical Supplies Administration stated that although Pfizer is the vaccine of choice for 16-60 year-olds, the Australian Technical Advisory Group on Immunization (ATAGI) recommends that in a large-scale outbreak, the benefits of the AZ vaccine outweigh the risks of side effects. . The Delta strain (the Indian variant COVID-19) has a higher risk of causing severe illness, especially among young people.
Adverse reactions after vaccination with AZ vaccine include pain at the injection site, swelling, tenderness, redness or itching, fatigue, headache, muscle pain, nausea, chills, fever, feeling unwell, and joint pain.
After vaccination, people who have the above symptoms should consult a doctor immediately. ◇
Editor in charge: Zong Minqing
For more real-time news and life information in Australia, please click dajiyuan.com.au
(This article shall not be reprinted or established a mirror website without permission)
.